Home > Aptamer Therapeutics > R&D Strategy and Aptamer

RIBOMIC, Inc. is a leading company in the world developing innovative aptamer therapeutics.

R&D Strategy and Aptamer

R&D Strategy and AptamerIn selecting the material for a new drug, our company sees four major pillars to choose from. We regard the antibodies among biological drug and drugs based on nucleic acids as the most advanced in terms of innovation.
   We believe aptamer therapeutics has the potential to become the core of the nucleic acid drugs.